OCD-155

N/A

Report date: 2025/01/26 17:24:55
NME

Base Information

Drug NameOCD-155
Drug Alias NameOCD-155
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncodrone BV
China Registration ClassN/A

Develop Information

Active CompaniesOncodrone BV
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A